Pharmaceutical / Drug Definition :
Enhances chloride-rich intestinal fluid secretion without altering sodium and potassium serum concentrations; increases intestinal fluid secretion and intestinal motility, which promotes stool passage and relieves symptoms of chronic idiopathic constipation
FDA Label Requirements and Exceptions
Lubiprostone
FDA Import Information
Lubiprostone
FDA Detentions
Lubiprostone (Lubiprostone Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Lubiprostone (Lubiprostone Suppliers)
- Processors Lubiprostone
- Repackers Lubiprostone
- Relabelers Lubiprostone
- Exporters Lubiprostone
- Importers Lubiprostone
For more information about Lubiprostone, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
